KCNQ1OT1/miR-18b/HMGA2 axis regulates high glucose-induced proliferation, oxidative stress, and extracellular matrix accumulation in mesangial cells

被引:15
作者
Li, Jia [1 ]
Li, Mingming [2 ]
Bai, Ling [3 ]
机构
[1] Navy 971 Hosp, Dept Nephrol, Qingdao 266000, Shandong, Peoples R China
[2] Shandong Energy Zaozhuang Min Grp Cent Hosp, Dept Endocrinol, Zaozhuang 277800, Shandong, Peoples R China
[3] Jining First Peoples Hosp, Dept Emergency Med, Nanchi Mansion Bldg 2, Jining 272000, Shandong, Peoples R China
关键词
Diabetic nephropathy; High glucose; KCNQ1OT1; miR-18b; HMGA2; DIABETIC-NEPHROPATHY; KCNQ1OT1; CONTRIBUTES; RESISTANCE; MIR-18B;
D O I
10.1007/s11010-020-03909-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The dysregulated long noncoding RNAs (lncRNAs) are associated with the pathogenesis of diabetic nephropathy (DN). LncRNA potassium voltage-gated channel subfamily Q member 1 overlapping transcript 1 (KCNQ1OT1) plays an important role in diabetes, but the role and mechanism of KCNQ1OT1 in DN are largely unknown. Serum samples were collected from 30 DN patients and normal volunteers. High glucose (HG)-challenged human mesangial cells (HMCs) were used as a cell model of DN. KCNQ1OT1, microRNA-18b (miR-18b), and high mobility group protein A2 (HMGA2) abundances were examined via quantitative reverse transcription polymerase chain reaction or western blot. Cell proliferation was assessed via 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide. Oxidative stress was assessed via the levels of reactive oxygen species (ROS), malondialdehyde (MDA), superoxide dismutase (SOD), and SOD2. Extracellular matrix (ECM) accumulation was investigated by the levels of fibronectin (FN), collagen I (Col I), and Col IV. The relationship between miR-18b and KCNQ1OT1 or HMGA2 was determined via dual-luciferase reporter analysis, RNA immunoprecipitation, and pull-down. KCNQ1OT1 expression was increased and miR-18b expression was decreased in DN patients and HG-challenged HMCs. miR-18b was targeted via KCNQ1OT1. Knockdown of KCNQ1OT1 weakened HG-caused proliferation, oxidative stress, and ECM accumulation of HMCs by increasing miR-18b. HMGA2 was targeted via miR-18b. miR-18b alleviated HG-induced cell proliferation, oxidative stress, and ECM accumulation by decreasing HMGA2. Silence of KCNQ1OT1 reduced HMGA2 expression via miR-18b. KCNQ1OT1 knockdown attenuated HG-induced proliferation, oxidative stress, and ECM accumulation of HMCs by regulating miR-18b/HMGA2 axis.
引用
收藏
页码:321 / 331
页数:11
相关论文
共 36 条
[1]   Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes [J].
Alkayyali, S. ;
Lajer, M. ;
Deshmukh, H. ;
Ahlqvist, E. ;
Colhoun, H. ;
Isomaa, B. ;
Rossing, P. ;
Groop, L. ;
Lyssenko, V. .
DIABETOLOGIA, 2013, 56 (02) :323-329
[2]   The role of non-coding RNAs in diabetic nephropathy: Potential applications as biomarkers for disease development and progression [J].
Alvarez, M. Lucrecia ;
DiStefano, Johanna K. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 99 (01) :1-11
[3]   Modelling diabetic nephropathy in mice [J].
Azushima, Kengo ;
Gurley, Susan B. ;
Coffman, Thomas M. .
NATURE REVIEWS NEPHROLOGY, 2018, 14 (01) :48-56
[4]   circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells [J].
Chen, Bin ;
Li, Yanhua ;
Liu, Yang ;
Xu, Zhonggao .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) :21249-21259
[5]   LncRNA KCNQ1OT1 accelerates fracture healing via modulating miR-701-3p/FGFR3 axis [J].
Chen, Lang ;
Xiong, Yuan ;
Yan, Chenchen ;
Zhou, Wu ;
Endo, Yori ;
Xue, Hang ;
Hu, Yiqiang ;
Hu, Liangcong ;
Leng, Xingzhu ;
Liu, Jing ;
Lin, Ze ;
Mi, Bobin ;
Liu, Guohui .
FASEB JOURNAL, 2020, 34 (04) :5208-5222
[6]   Diabetic nephropathy: A potential savior with 'rotten-egg' smell [J].
Dugbartey, George J. .
PHARMACOLOGICAL REPORTS, 2017, 69 (02) :331-339
[7]   Diabetic nephropathy: diagnosis and treatment [J].
Fineberg, Daniel ;
Jandeleit-Dahm, Karin A. M. ;
Cooper, Mark E. .
NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (12) :713-723
[8]  
Geng N, 2018, EUR REV MED PHARMACO, V22, P3826, DOI 10.26355/eurrev_201806_15267
[9]  
Huntington disease, 2015, Nat Rev Dis Primers, V1, P15052, DOI [DOI 10.1038/NRDP.2015.18, 10.1038/nrdp.2015.52]
[10]   Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy [J].
Ilyas, Zubair ;
Chaiban, Joumana T. ;
Krikorian, Armand .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2017, 18 (01) :21-28